Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
J Keith Joung
Affiliation
Massachusetts General Hospital
ORCID
Career Start Year
1993
Papers
152
H Index
75
Expertise
CM4AI Collaborator
Prashant Mali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36163548
Engineered CRISPR prime editors with compact, untethered reverse transcriptases.
Nat Biotechnol
2023
37796769
Functional analysis of Collagen 17a1: A genetic modifier of junctional epidermolysis bullosa in mice.
PLoS One
2023
37645936
Enhancing CRISPR prime editing by reducing misfolded pegRNA interactions.
bioRxiv
2023
37292647
Gene editing without <i>ex vivo</i> culture evades genotoxicity in human hematopoietic stem cells.
bioRxiv
2023
37183825
Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state.
J Clin Invest
2023
36909587
Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell State.
bioRxiv
2023
33986547
Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells.
Nat Biotechnol
2022
35505961
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease <i>PSEN</i> <i>1</i> M146L mutation.
Mol Ther Nucleic Acids
2022
35761069
Author Correction: Augmenting and directing long-range CRISPR-mediated activation in human cells.
Nat Methods
2022
36520914
Multidimensional control of therapeutic human cell function with synthetic gene circuits.
Science
2022
35967079
Genome-wide functional perturbation of human microsatellite repeats using engineered zinc finger transcription factors.
Cell Genom
2022
33927418
CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells.
Nat Biotechnol
2022
32661438
Optimization of AsCas12a for combinatorial genetic screens in human cells.
Nat Biotechnol
2021
33547443
Scalable characterization of the PAM requirements of CRISPR-Cas enzymes using HT-PAMDA.
Nat Protoc
2021
33571044
A Code of Ethics for Gene Drive Research.
CRISPR J
2021
34773119
Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.
Nat Protoc
2021
34050017
Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito.
Proc Natl Acad Sci U S A
2021
34354266
Augmenting and directing long-range CRISPR-mediated activation in human cells.
Nat Methods
2021
32541959
Publisher Correction: Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.
Nat Biotechnol
2020
31685652
Zebrafish <i>dscaml1</i> Deficiency Impairs Retinal Patterning and Oculomotor Function.
J Neurosci
2020
32900862
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources.
J Immunother Cancer
2020
30995674
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors.
Nature
2019
29972722
Activities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize.
Plant Biotechnol J
2019
31477922
CRISPR DNA base editors with reduced RNA off-target and self-editing activities.
Nat Biotechnol
2019
30867611
Adopt a moratorium on heritable genome editing.
Nature
2019
30742127
Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.
Nat Biotechnol
2019
29326244
Gene therapy comes of age.
Science
2018
29998038
Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs.
Nat Biomed Eng
2018
30190308
Discovery of widespread type I and type V CRISPR-Cas inhibitors.
Science
2018
29858078
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease.
Mol Ther Nucleic Acids
2018
30209390
In vivo CRISPR editing with no detectable genome-wide off-target mutations.
Nature
2018
30059493
An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities.
Nat Biotechnol
2018
29947794
Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
Nucleic Acids Res
2018
31021199
Impact of Genetic Variation on CRISPR-Cas Targeting.
CRISPR J
2018
30341435
Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq.
Nat Protoc
2018
30504875
CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data.
Nat Methods
2018
29724820
Temporal and Spatial Post-Transcriptional Regulation of Zebrafish <i>tie1</i> mRNA by Long Noncoding RNA During Brain Vascular Assembly.
Arterioscler Thromb Vasc Biol
2018
29600992
Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Nat Methods
2018
28576875
Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway.
Blood
2017
28415827
Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.
Oncotarget
2017
28459458
CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets.
Nat Methods
2017
29083402
Inducible and multiplex gene regulation using CRISPR-Cpf1-based transcription factors.
Nat Methods
2017
29215332
Nodal patterning without Lefty inhibitory feedback is functional but fragile.
Elife
2017
28931002
Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.
Nature
2017
26735016
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
Nature
2016
27231123
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma.
Cancer Discov
2016
27347757
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
Nat Biotechnol
2016
27153277
Open-source guideseq software for analysis of GUIDE-seq data.
Nat Biotechnol
2016
27087594
Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases.
Nat Rev Genet
2016
25357182
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo.
Nat Biotechnol
2015
1 - 50 of 152
Column Actions
Search
Recommended Authors
George M Church
Wyss Institute for Biologically Inspired Engineering, Harvard University
Career Start Year
2018
Number of shared co-authors
2
Soh Ishiguro
The University of British Columbia
Career Start Year
2018
Number of shared co-authors
1
Jared Carlson-Stevermer
Synthego Corporation
Career Start Year
2015
Number of shared co-authors
2
David B T Cox
Broad Institute of MIT and Harvard
Career Start Year
2013
Number of shared co-authors
3
James E DiCarlo
Brigham & Women's Hospital and Harvard Medical School
Career Start Year
2013
Number of shared co-authors
1
Jonathan S Gootenberg
McGovern Institute for Brain Research at MIT Massachusetts Institute of Technology
Career Start Year
2013
Number of shared co-authors
4
Omar O Abudayyeh
McGovern Institute for Brain Research at MIT Massachusetts Institute of Technology
Career Start Year
2012
Number of shared co-authors
4
Luhan Yang
College of Resources and Environment, Southwest University
Career Start Year
2012
Number of shared co-authors
4
Mahmut Parlak
University of Virginia
Career Start Year
2012
Number of shared co-authors
0
Debojyoti Chakraborty
CSIR-Institute of Genomics & Integrative Biology
Career Start Year
2012
Number of shared co-authors
0
Max A Horlbeck
Broad Institute of MIT and Harvard
Career Start Year
2012
Number of shared co-authors
1
Cory Smith
GC Therapeutics Inc.
Career Start Year
2011
Number of shared co-authors
4
Marc G??ell
Universitat Pompeu Fabra
Career Start Year
2009
Number of shared co-authors
3
Patrick D Hsu
University of California berkeley
Career Start Year
2009
Number of shared co-authors
6
Joyce L Yang
Beth Israel Deaconess Medical Center and Harvard Medical School
Career Start Year
2008
Number of shared co-authors
2
Lei S Qi
Stanford University
Career Start Year
2008
Number of shared co-authors
5
Ophir Shalem
Perelman School of Medicine, University of Pennsylvania
Career Start Year
2008
Number of shared co-authors
2
Branden S Moriarity
University of Minnesota
Career Start Year
2007
Number of shared co-authors
1
Luke A Gilbert
Arc Institute
Career Start Year
2007
Number of shared co-authors
6
Nozomu Yachie
The University of British Columbia
Career Start Year
2006
Number of shared co-authors
3
Alan S L Wong
The University of Hong Kong
Career Start Year
2005
Number of shared co-authors
2
Haoyi Wang
Chinese Academy of Sciences
Career Start Year
2003
Number of shared co-authors
2
John Aach
Harvard Medical School
Career Start Year
2000
Number of shared co-authors
4
Jay Shendure
University of Washington
Career Start Year
1996
Number of shared co-authors
4
Gregory J Cost
Metagenomi Inc., Pre-clinical
Career Start Year
1995
Number of shared co-authors
0
Seung Woo Cho
Center for Genomic Integrity, Institute for Basic Science
Career Start Year
1995
Number of shared co-authors
2
Fyodor D Urnov
Innovative Genomics Institute, University of California berkeley
Career Start Year
1993
Number of shared co-authors
6
Frank Buchholz
University Hospital Carl Gustav Carus, Technische Universitat (TU) Dresden
Career Start Year
1989
Number of shared co-authors
0
George M Church
Harvard Medical School
Career Start Year
1977
Number of shared co-authors
13
Jin-Soo Kim
Exercise Medicine Research Institute, Edith Cowan University
Career Start Year
1973
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Morgan L Maeder
Massachusetts General Hospital, Harvard Medical School
Co-authored papers
31
Benjamin P Kleinstiver
Center for Genomic Medicine, Massachusetts General Hospital
Co-authored papers
19
Stacey Thibodeau-Beganny
Amherst College
Co-authored papers
16
Luca Pinello
Co-authored papers
13
Matthew H Porteus
Stanford University
Co-authored papers
6
David R Liu
Co-authored papers
5
Sowmya Iyer
Co-authored papers
5
Sara P Garcia
Co-authored papers
4
Shondra M Pruett-Miller
St. Jude Children's Research Hospital.
Co-authored papers
4
Scot A Wolfe
Co-authored papers
4
Anthony J Iafrate
Massachusetts General Hospital
Co-authored papers
4
Bradley E Bernstein
Broad Institute of MIT and Harvard
Co-authored papers
3
Daniel E Bauer
Co-authored papers
3
Alex Look
Dana-Farber Cancer Institute
Co-authored papers
3
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers
3
Dennis C Sgroi
Co-authored papers
2
Jizhong Zou
and Blood Institute, National Institutes of Health
Co-authored papers
2
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers
2
Vilmantas Giedraitis
Co-authored papers
2
Frederic D Bushman
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
2
Xandra O Breakefield
Massachusetts General Hospital
Co-authored papers
2
John G Doench
Co-authored papers
2
Sharon J Diskin
Children's Hospital of Philadelphia
Co-authored papers
2
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers
2
Martin Ingelsson
Co-authored papers
2
David M Langenau
MGH Pathology and Harvard Medical School
Co-authored papers
2
Feng Zhang
Massachusetts Institute of Technology, USA Broad Institute
Co-authored papers
2
John M Maris
Children's Hospital of Philadelphia
Co-authored papers
2
Shizhen Zhu
Co-authored papers
2
Hanns Lochm??ller
Children's Hospital of Eastern Ontario Research Institute
Co-authored papers
1
1 - 30